Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus?

Coronary artery disease (CAD) is a major cause of morbidity and mortality in patients with diabetes mellitus. In real-world registries of patients undergoing percutaneous coronary intervention (PCI), diabetic patients account for between 20 and 45% of treated of patients. Although improvements in preventive care for patients with diabetes in recent years has substantially reduced rates of cardiovascular complications, the incidence of acute myocardial infarction remains approximately five times higher in patients with versus those without diabetes mellitus.